| Date Filed | Type | Description |
| 08/15/2023 |
4
| FOEHR MATTHEW W (President and CEO) has filed a Form 4 on OmniAb, Inc.|
Txns:
| Bought 45,000 shares
@ $5.48, valued at
$246.6k
|
|
| 06/12/2023 |
4
| FOEHR MATTHEW W (CEO) has filed a Form 4 on OmniAb, Inc.|
Txns:
| Bought 115,000 shares
@ $4.52, valued at
$519.8k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| FOEHR MATTHEW W (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $8.52, valued at
$187.4k
|
|
| 12/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/30/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2022 |
4
| FOEHR MATTHEW W (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Bought 45,000 shares
@ $2.471, valued at
$111.2k
|
|
| 02/16/2022 |
4
| FOEHR MATTHEW W (President and COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 1,234 shares
@ $123.68, valued at
$152.6k
Paid exercise price by delivering 1,222 shares
@ $123.68, valued at
$151.1k
Paid exercise price by delivering 1,090 shares
@ $123.68, valued at
$134.8k
|
|
| 01/28/2022 |
4
| FOEHR MATTHEW W (President and COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 5,604 shares
@ $0
Granted 7,396 shares
@ $0
Paid exercise price by delivering 1,937 shares
@ $113.68, valued at
$220.2k
Paid exercise price by delivering 3,188 shares
@ $113.68, valued at
$362.4k
|
|
| 01/05/2022 |
4
| FOEHR MATTHEW W (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $4.88, valued at
$107.4k
|
|
| 11/12/2021 |
4
| FOEHR MATTHEW W (President and COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 11,160 shares
@ $163.0157, valued at
$1.8M
Exercised 11,160 options to buy
@ $21.92, valued at
$244.6k
Exercised 1,028 options to buy
@ $100.38, valued at
$103.2k
|
|
| 08/05/2021 |
4
| FOEHR MATTHEW W (President and COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 8,840 shares
@ $109.6727, valued at
$969.5k
Exercised 8,840 options to buy
@ $21.92, valued at
$193.8k
Exercised 1,142 options to buy
@ $85.79, valued at
$98k
|
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| FOEHR MATTHEW W (President and COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 2,911 shares
@ $0
Paid exercise price by delivering 1,053 shares
@ $156.01, valued at
$164.3k
Granted 5,604 shares
@ $0
Paid exercise price by delivering 2,272 shares
@ $156.01, valued at
$354.5k
|
|
| 01/06/2021 |
4
| FOEHR MATTHEW W (Director) has filed a Form 4 on Viking Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $5.8, valued at
$127.6k
|
|
| 08/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/24/2020 |
4
| FOEHR MATTHEW W (President and COO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Paid exercise price by delivering 938 shares
@ $120.86, valued at
$113.4k
Paid exercise price by delivering 1,246 shares
@ $120.86, valued at
$150.6k
Paid exercise price by delivering 642 shares
@ $120.86, valued at
$77.6k
|
|
|